Vanderbilt Center for Antibody Therapeutics (VCAT) Archive — Page 2 of 13
-
November 15, 2023
Twelve at Vanderbilt are among world’s highly cited researchers
Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers. -
October 30, 2023
Crowe, Osheroff honored by AAMC
Vanderbilt's James E. Crowe, Jr, MD, and Neil Osheroff, PhD, are among 12 individuals honored by the Association of American Medical Colleges during its 2023 Awards Recognition Event. -
September 13, 2023
James Crowe’s antibody research lands American Society for Microbiology Award
Vanderbilt University Medical Center’s James Crowe Jr., MD, has been named to receive the 2024 American Society for Microbiology Award for Applied and Biotechnological Research. -
August 4, 2023
Researchers discover antibody that neutralizes both RSV and hMPV
Vanderbilt and Stanford University researchers discovered a potent, cross-neutralizing human monoclonal antibody against the respiratory syncytial virus and human metapneumovirus. -
June 22, 2023
VUMC, Oxford team develops ‘blueprint’ to block lethal virus
Researchers at Vanderbilt University Medical Center and the University of Oxford have determined how a human monoclonal antibody isolated at Vanderbilt in 2021 can prevent infection by the potentially lethal Sin Nombre virus. -
March 30, 2023
Crowe, Harris, Young elected as new AIMBE fellows
Vanderbilt's James Crowe Jr., MD, Paul Harris, PhD, and Jamey Young, PhD, have been elected to the 2023 College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE). -
March 23, 2023
Crowe’s research honored
Vanderbilt's James Crowe Jr., MD, was among those to receive 2023 Advocacy Awards from Research!America at the biomedical research advocacy organization’s annual awards program in Washington, D.C.